Cato Institute
1000 Massachusetts Ave, NW
Washington, DC 20001-5403
 Phone (202) 842 0200
Fax (202) 842 3490
 Contact Us
Support Cato

Why FDA Regulation Is a Death Sentence for the Terminally Ill

POLICY FORUM
Thursday, June 10, 2004
12:00 pm

Featuring Frank Burroughs, President and Founder, Abigail Alliance; Steve Walker, Regulatory Advisor, Abigail Alliance; and David Price, Counsel, Washington Legal Foundation.

The Cato Institute
1000 Massachusetts Avenue, NW
Washington, DC 20001


tv Watch the Event in Real Video
Listen to the Event in Real Audio (Audio Only)

Food and Drug Administration regulations deny terminally ill patients access to experimental drugs that could prolong or save their lives. Charging that this policy "operates as a death sentence for those patients," the Abigail Alliance for Better Access to Developmental Drugs has filed a citizen petition with -- and a lawsuit against -- the FDA. A few of the people behind the Abigail Alliance will discuss what it really means to fight for patients' rights.

Cato Institute • 1000 Massachusetts Avenue, N.W. • Washington D.C. 20001-5403
Phone (202) 842-0200 • Fax (202) 842-3490